← Back to all trials
Recruiting
NCT07852273
Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Conditions: Inflamatory Bowel Disease, Crohn Disease (CD)
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 40
Sponsor: Case Western Reserve University
Location: UH Minoff Health Center Chagrin Falls Ohio
Summary
This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with Inflammatory Bowel Disease (IBD), compared to healthy non-IBD individuals. We will focus on studying IBD patients affected with Crohn's Disease (CD) as a proof of principle that could be tested later in other IBD subtypes (ulcerative colitis or others specific surgical conditions).
Eligibility Criteria
Inclusion Criteria:
* Age range from 18 to 75 years
* Male or female
* Documented diagnosis of Crohns disease. CD outpatients in remission; Harvey Bradshaw- index in remission (\
Source: ClinicalTrials.gov (NCT07852273). StuddyBuddy aggregates publicly available trial information.